| Literature DB >> 25691626 |
Neelima Mishra1, Surendra Kumar Prajapati1, Kamlesh Kaitholia1, Ram Suresh Bharti1, Bina Srivastava1, Sobhan Phookan1, Anupkumar R Anvikar1, Vas Dev1, Gagan Singh Sonal2, Akshay Chandra Dhariwal2, Nicholas J White3, Neena Valecha4.
Abstract
Malaria treatment in Southeast Asia is threatened with the emergence of artemisinin-resistant Plasmodium falciparum. Genome association studies have strongly linked a locus on P. falciparum chromosome 13 to artemisinin resistance, and recently, mutations in the kelch13 propeller region (Pfk-13) were strongly linked to resistance. To date, this information has not been shown in Indian samples. Pfk-13 mutations were assessed in samples from efficacy studies of artemisinin combination treatments in India. Samples were PCR amplified and sequenced from codon 427 to 727. Out of 384 samples, nonsynonymous mutations in the propeller region were found in four patients from the northeastern states, but their presence did not correlate with ACT treatment failures. This is the first report of Pfk-13 point mutations from India. Further phenotyping and genotyping studies are required to assess the status of artemisinin resistance in this region.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25691626 PMCID: PMC4394795 DOI: 10.1128/AAC.04632-14
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.191